Prostate cancer is the most common form of cancer among men in England, with cases surging by 25 per cent between 2019 and 2023, according to NHS data. It’s also the second-deadliest form of the ...
Tribune Content Agency on MSN
What is a PSA test and how is it used?
In this two-part series, we'll describe the PSA test-- how it's used, and how doctors perform next steps in the event of an abnormal reading. Our first post addresses PSA screening for prostate cancer ...
PSA stands for prostate-specific antigen, a substance naturally produced in prostate tissue. A small amount of PSA regularly sneaks into the bloodstream, and low blood concentration is considered ...
Screening PSA levels at aged 65-69 may inform the decision to continue or discontinue prostate cancer screening after age 70 years, regardless of patient race and ethnicity. The absolute risks of ...
Prostate-specific antigen (PSA) testing may not accurately pinpoint levels at which transgender women on estrogen therapy may be at risk of developing prostate cancer, according to data from the ...
Akshay Kumar highlights the importance of PSA testing after losing his father to prostate cancer. Learn what a PSA test is ...
The Stockholm3 blood test is equally effective at detecting prostate cancer in different ethnic groups, a new paper reports. The test produces significantly better results than the current PSA ...
BOSTON -- A disturbing new study has found that 15 percent of older men with supposedly normal readings on the widely used PSA test have prostate cancer anyway -- and some even have aggressive tumors.
A new British study suggests that the prostate-specific antigen (PSA) test, long used to spot prostate cancers, might lead to overdiagnosis in Black men. Researchers now theorize that Black men may ...
PSA levels can be elevated for reasons other than cancer, such as an enlarged or inflamed prostate. False positive and false negative PSA test results are possible. The American Cancer Society does ...
Stockholm3, a prostate cancer test developed in Sweden, runs a combination of protein and genetic markers from a blood sample through an algorithm to find the probability of a patient having ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results